| For: | Liu YS, Li HS, Qi DF, Zhang J, Jiang XC, Shi K, Zhang XJ, Zhang XH. Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin. World J Gastroenterol 2014; 20(26): 8572-8582 [PMID: 25024611 DOI: 10.3748/wjg.v20.i26.8572] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8572.htm |
| Number | Citing Articles |
| 1 |
Xiao-Meng Liu, Zhe Li, Xiao-Ya Wang, Bo-Wen Ding, Jia-Qian Wang, Xin Qiao, Yu-Kuan Feng, Ji-Hui Hao, Jing-Yuan Xu. Self-assembled HO-1i-Pt(IV) nanomedicine targeting p38/MAPK and MDR pathways for cancer chemo-immunotherapy. Journal of Controlled Release 2025; 379 doi: 10.1016/j.jconrel.2025.01.050
|
| 2 |
Jose D. Puentes-Pardo, Sara Moreno-SanJuan, Ángel Carazo, Josefa León. Heme Oxygenase-1 in Gastrointestinal Tract Health and Disease. Antioxidants 2020; 9(12) doi: 10.3390/antiox9121214
|
| 3 |
Valeria Consoli, Valeria Sorrenti, Salvo Grosso, Luca Vanella. Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions. Biomolecules 2021; 11(4) doi: 10.3390/biom11040589
|
| 4 |
Shih-Kai Chiang, Shuen-Ei Chen, Ling-Chu Chang. The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival. Cells 2021; 10(9) doi: 10.3390/cells10092401
|
| 5 |
Yuki Yamada, Tomoko Uchiyama, Fuminori Ito, Naoki Kawahara, Kenji Ogawa, Chiho Obayashi, Hiroshi Kobayashi. Clinical significance of M2 macrophages expressing heme oxygenase-1 in malignant transformation of ovarian endometrioma. Pathology - Research and Practice 2019; 215(4) doi: 10.1016/j.prp.2018.12.017
|
| 6 |
Jiyan Mohammad, Rahul R. Singh, Cody Riggle, Brandon Haugrud, Maher Y. Abdalla, Katie M. Reindl. JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells. Apoptosis 2019; 24(9-10) doi: 10.1007/s10495-019-01553-9
|
| 7 |
Rihui Wu, Xueting Mei, Yibiao Ye, Ting Xue, Jiasheng Wang, Wenjia Sun, Caixia Lin, Ruoxue Xue, Jiabao Zhang, Donghui Xu. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis. Pharmacological Research 2019; 150 doi: 10.1016/j.phrs.2019.104454
|
| 8 |
Vafa Baradaran Rahimi, Vahid Reza Askari, Seyed Hadi Mousavi. Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study. Biomedicine & Pharmacotherapy 2018; 108 doi: 10.1016/j.biopha.2018.10.024
|
| 9 |
Zhongqiang Cheng, Lixian Huang, Yanshu Zhang, Kaiyue Yue, Shunmo Jia, Zhijie Fang, Zhiqiang Lin. Heme oxygenase-1 leads to cisplatin resistance in nasopharyngeal carcinoma by reducing oxidative stress and ferroptosis. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03908-6
|
| 10 |
Shih-Kai Chiang, Shuen-Ei Chen, Ling-Chu Chang. A Dual Role of Heme Oxygenase-1 in Cancer Cells. International Journal of Molecular Sciences 2018; 20(1) doi: 10.3390/ijms20010039
|
| 11 |
Xiaojing Lin, Qin Fang, Shuya Chen, Nana Zhe, Qixiang Chai, Meisheng Yu, Yaming Zhang, Ziming Wang, Jishi Wang. Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway. Leukemia Research 2015; 39(5) doi: 10.1016/j.leukres.2015.02.009
|
| 12 |
Leslie C. Costello, Renty B. Franklin. Decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas. Expert Opinion on Therapeutic Targets 2017; 21(1) doi: 10.1080/14728222.2017.1265506
|
| 13 |
Daolin Tang, Rui Kang. NFE2L2 and ferroptosis resistance in cancer therapy. Cancer Drug Resistance 2024; doi: 10.20517/cdr.2024.123
|
| 14 |
Sonny C. Ramos, Seung-Hyun Jeong, Yong-An Lee, Jong-Jin Kim. Emerging roles of heme oxygenase 2 (HO-2) in cancer: Implications for diagnosis and therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2026; 1872(1) doi: 10.1016/j.bbadis.2025.168057
|
| 15 |
Mariarita Spampinato, Giuseppe Sferrazzo, Valeria Pittalà, Michelino Di Rosa, Luca Vanella, Loredana Salerno, Valeria Sorrenti, Giuseppe Carota, Nunziatina Parrinello, Marco Raffaele, Daniele Tibullo, Giovanni Li Volti, Ignazio Barbagallo. Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation. Molecular Biology Reports 2020; 47(3) doi: 10.1007/s11033-020-05292-y
|
| 16 |
Zhaowen Zhu, Huy Tran, Meleah M. Mathahs, Brian D. Fink, John A. Albert, Thomas O. Moninger, Jeffery L. Meier, Ming Li, Warren N. Schmidt. Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity*. Pharmacology Research & Perspectives 2021; 9(6) doi: 10.1002/prp2.882
|
| 17 |
Carlo Castruccio Castracani, Lucia Longhitano, Alfio Distefano, Michelino Di Rosa, Valeria Pittalà, Gabriella Lupo, Massimo Caruso, Daniela Corona, Daniele Tibullo, Giovanni Li Volti. Heme Oxygenase-1 and Carbon Monoxide Regulate Growth and Progression in Glioblastoma Cells. Molecular Neurobiology 2020; 57(5) doi: 10.1007/s12035-020-01869-7
|
| 18 |
Yi-Tai Chou, Fu-Fei Hsu, Dun-Yao Hu, Ying-Chih Chen, Yuan-Hao Hsu, John T.-A. Hsu, Lee-Young Chau. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0411-y
|
| 19 |
Tejas Girish Agnihotri, Shyam Sudhakar Gomte, Biswajit Rout, Vasu Peddinti, Sandeep Kr Maharana, Devaraj Yallappa, Aakanchha Jain. Emerging Strategies in Cancer Metabolism. 2026; doi: 10.1016/B978-0-443-33459-7.00006-5
|
| 20 |
Katherine Hu, Zhaowen Zhu, Meleah M Mathahs, Huy Tran, Jerry Bommer, Charles A Testa, Warren N Schmidt. <p>Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships</p>. Drug Design, Development and Therapy 2020; doi: 10.2147/DDDT.S201089
|
| 21 |
Pengfei Shi, Jie Xu, Hongjuan Cui. Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy. International Journal of Biological Macromolecules 2025; 310 doi: 10.1016/j.ijbiomac.2025.143375
|
| 22 |
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, Hossein Saleki, Seyed Mohammad Reza Torabi, Adnan Ranjbar, SeyedHesam SeyedSaleh, Seyed Omid Sharifzadeh, Haroon Khan, Milad Ashrafizadeh, Ali Zarrabi, Kwang-seok Ahn. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 2021; 26(8) doi: 10.3390/molecules26082382
|
| 23 |
Rebeca García-Varela, Oscar Raúl Fajardo Ramírez, Sergio O. Serna-Saldivar, Julio Altamirano, Guy A. Cardineau. Cancer cell specific cytotoxic effect of Rhoeo discolor extracts and solvent fractions. Journal of Ethnopharmacology 2016; 190 doi: 10.1016/j.jep.2016.05.051
|
| 24 |
Mariapaola Nitti, Sabrina Piras, Umberto Marinari, Lorenzo Moretta, Maria Pronzato, Anna Furfaro. HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation. Antioxidants 2017; 6(2) doi: 10.3390/antiox6020029
|
| 25 |
Chun-Chia Cheng, Siao-Syun Guan, Hao-Jhih Yang, Chun-Chao Chang, Tsai-Yueh Luo, Jungshan Chang, Ai-Sheng Ho. Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer. Journal of Biomedical Science 2016; 23(1) doi: 10.1186/s12929-016-0219-6
|
| 26 |
Kui Long, Zhitian Shi, Weiran Liao, Yutao He, Lixin Liu, Lin Wang. Dehydrocostus lactone promotes ferroptosis by regulating the HMOX1/CDK1 axis during liver cancer treatment. Bioorganic Chemistry 2026; 168 doi: 10.1016/j.bioorg.2025.109349
|
| 27 |
Z. Zhao, Y. Xu, J. Lu, J. Xue, P. Liu. High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells. Clinical and Translational Oncology 2018; 20(4) doi: 10.1007/s12094-017-1738-7
|
| 28 |
Zhihan Liu, Ping Cheng, Tao Feng, Zhiyuan Xie, Meifang Yang, Zhiren Chen, Shuqun Hu, Dong Han, Weiwei Chen. Nrf2/HO-1 blocks TXNIP/NLRP3 interaction via elimination of ROS in oxygen-glucose deprivation-induced neuronal necroptosis. Brain Research 2023; 1817 doi: 10.1016/j.brainres.2023.148482
|
| 29 |
Jinjing Xu, Kuiyang Zhu, Yali Wang, Jing Chen. The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection. Journal of Cancer Research and Clinical Oncology 2023; 149(1) doi: 10.1007/s00432-022-04447-7
|
| 30 |
Chilakala Nagarjuna Reddy, Abhisheik Chowdary Eedara, Sumera Malik, Dilip M. Mondhe, Sandip B. Bharate, Sai Balaji Andugulapati. 7S,15R-Stereoisomer of phenylethylamino derivative of colchicine exhibits potent in-vitro and in-vivo anti-cancer activity against prostate Cancer: Assessing the impact of stereochemistry on biological activity. Bioorganic Chemistry 2025; 157 doi: 10.1016/j.bioorg.2025.108262
|
| 31 |
Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso, Anna Lisa Furfaro. Clinical Significance of Heme Oxygenase 1 in Tumor Progression. Antioxidants 2021; 10(5) doi: 10.3390/antiox10050789
|
| 32 |
Kun-Chun Chiang, Kang-Shuo Chang, Shu-Yuan Hsu, Hsin-Ching Sung, Tsui-Hsia Feng, Mei Chao, Horng-Heng Juang. Human Heme Oxygenase-1 Induced by Interleukin-6 via JAK/STAT3 Pathways Is a Tumor Suppressor Gene in Hepatoma Cells. Antioxidants 2020; 9(3) doi: 10.3390/antiox9030251
|
| 33 |
Lee-Young Chau. Heme oxygenase-1: emerging target of cancer therapy. Journal of Biomedical Science 2015; 22(1) doi: 10.1186/s12929-015-0128-0
|
| 34 |
J. Catharina Duvigneau, Harald Esterbauer, Andrey V. Kozlov. Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways. Antioxidants 2019; 8(10) doi: 10.3390/antiox8100475
|
| 35 |
Chutima Talabnin, Krajang Talabnin, Sopit Wongkham. Enhancement of piperlongumine chemosensitivity by silencing heme oxygenase‑1 expression in cholangiocarcinoma cell lines. Oncology Letters 2020; 20(3) doi: 10.3892/ol.2020.11784
|
| 36 |
Ayleen Fernández-Fierro, Samanta C. Funes, Mariana Rios, Camila Covián, Jorge González, Alexis M. Kalergis. Immune Modulation by Inhibitors of the HO System. International Journal of Molecular Sciences 2020; 22(1) doi: 10.3390/ijms22010294
|
| 37 |
Tianzhuo Zhang, Danna Wei, Yun Zhan, Zhengmei Long, Tingting Lu, Peng Zhao, Rui Gao, Qian Kang, Luxin Zhang, Min Liu, Xueying Yang, Jishi Wang. Heme oxygenase 1 confers gilteritinib resistance in FLT3-ITD acute myeloid leukemia in a STAT6-dependent manner. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03757-3
|